Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CCXX.U
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
|
+$30.5M |
| 2 |
AGN
Allergan plc
AGN
|
+$26.9M |
| 3 |
IPHI
INPHI CORPORATION
IPHI
|
+$23.4M |
| 4 |
Bilibili
BILI
|
+$21.7M |
| 5 |
Gaotu Techedu
GOTU
|
+$16.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vistra
VST
|
+$89.7M |
| 2 |
Dominion Energy
D
|
+$69.9M |
| 3 |
Cheniere Energy
LNG
|
+$63.1M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$62.8M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$53.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.3% |
| 2 | Financials | 15.11% |
| 3 | Consumer Discretionary | 13.23% |
| 4 | Healthcare | 12.79% |
| 5 | Communication Services | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Elevance Health
ELV
$86.9B
| $594K | 0.04% |
2,617
+714
| +38% | +$195K |
|
527
Ionis Pharmaceuticals
IONS
$9.93B
| $588K | 0.04% |
+12,436
| New | +$693K |
|
528
ATI
ATI
$28.2B
| $587K | 0.04% |
69,000
+41,256
| +149% | +$659K |
|
|
DOC
529
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $587K | 0.04% |
+42,100
| New | +$774K |
|
|
SF
530
Stifel
SF
$12.2B
| $586K | 0.04% |
+31,950
| New | +$800K |
|
531
United Airlines
UAL
$36.7B
| $585K | 0.04% |
18,550
-91,495
| -83% | -$6.05M |
|
532
Knowles
KN
$2.85B
| $583K | 0.04% |
43,600
+21,400
| +96% | +$372K |
|
|
GAP
533
The Gap Inc
GAP
$7.13B
| $582K | 0.04% |
+82,600
| New | +$1.23M |
|
534
Granite Construction
GVA
$5.5B
| $580K | 0.04% |
+38,200
| New | +$858K |
|
535
Delta Air Lines
DAL
$54.2B
| $574K | 0.04% |
+20,116
| New | +$997K |
|
536
TransDigm Group
TDG
$66.4B
| $573K | 0.04% |
1,789
-20,811
| -92% | -$11.3M |
|
537
UDR
UDR
$12.1B
| $569K | 0.04% |
+15,583
| New | +$705K |
|
538
Invesco Mortgage Capital
IVR
$809M
| $568K | 0.04% |
16,660
+11,934
| +253% | +$1.75M |
|
539
Flowserve
FLS
$10.1B
| $567K | 0.04% |
23,714
+11,860
| +100% | +$479K |
|
540
10x Genomics
TXG
$8.48B
| $567K | 0.04% |
+9,100
| New | +$710K |
|
|
RDHL
541
Redhill Biopharma
RDHL
$3.83M
| $566K | 0.04% |
125
+108
| +635% | +$540K |
|
542
Tenable Holdings
TENB
$3.79B
| $563K | 0.04% |
25,757
+15,857
| +160% | +$392K |
|
|
IRBT
543
DELISTED
iRobot
IRBT
| $559K | 0.04% |
13,658
+4,658
| +52% | +$224K |
|
544
Akamai
AKAM
$15.9B
| $558K | 0.04% |
6,094
+3,759
| +161% | +$349K |
|
|
ARYAU
545
DELISTED
ARYA Sciences Acquisiton Corp. Unit
ARYAU
| $556K | 0.04% |
50,500
-666,500
| -93% | -$7.68M |
|
546
DaVita
DVA
$11.1B
| $554K | 0.03% |
7,290
-4,715
| -39% | -$371K |
|
|
MRSH
547
Marsh
MRSH
$91.6B
| $553K | 0.03% |
+6,400
| New | +$682K |
|
|
SCS
548
DELISTED
Steelcase
SCS
| $551K | 0.03% |
55,800
+40,300
| +260% | +$665K |
|
549
Halliburton
HAL
$29.4B
| $550K | 0.03% |
80,296
+49,808
| +163% | +$867K |
|
550
Starwood Property Trust
STWD
$6.06B
| $544K | 0.03% |
53,100
+36,382
| +218% | +$797K |
|
Similar funds
Steve Schonfeld's Q1 2020 Portfolio in Review
As of Q1 2020, Steve Schonfeld held 1,717 positions worth $1.59B, down 61% from $4.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Steve Schonfeld withdrew a net $1.91B in Q1 2020, closing 624 positions and reducing 338 holdings. Its most notable exit was Vistra, an estimated $89.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Steve Schonfeld opened a new position in Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt worth $30M.
- Steve Schonfeld's largest Q1 2020 buy was Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt: 3,000,000 shares worth $30M.
- Steve Schonfeld added most to Allergan plc in Q1 2020, an estimated $26.9M increase.
- Steve Schonfeld's biggest Q1 2020 reduction was Cheniere Energy, cutting an estimated $63.1M.
- Steve Schonfeld fully exited Vistra in Q1 2020, selling an estimated $89.7M.
- Steve Schonfeld's ten largest holdings make up 16% of its $1.59B portfolio in Q1 2020.
- Steve Schonfeld opened 455 new positions and closed 624 in Q1 2020.
- Steve Schonfeld's portfolio value fell 61% quarter-over-quarter to $1.59B.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2020, filed 15 May 2020.